UK Pediatric Diabetes Management Market Size & Outlook
Related Markets
UK pediatric diabetes management market highlights
- The UK pediatric diabetes management market generated a revenue of USD 239.3 million in 2024 and is expected to reach USD 559.8 million by 2033.
- The UK market is expected to grow at a CAGR of 9.9% from 2025 to 2033.
- In terms of segment, cgm was the largest revenue generating product in 2024.
- CGM is the most lucrative product segment registering the fastest growth during the forecast period.
Pediatric diabetes management market data book summary
| Market revenue in 2024 | USD 239.3 million |
| Market revenue in 2033 | USD 559.8 million |
| Growth rate | 9.9% (CAGR from 2025 to 2033) |
| Largest segment | Cgm |
| Fastest growing segment | CGM |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | BGM, CGM, Insulin Pumps, Insulin Pens, Insulin Syringes |
| Key market players worldwide | Medtronic PLC, DexCom Inc, Abbott, Tandem Diabetes Care Inc, Insulet Corp, Novo Nordisk A/S, Sanofi SA, Eli Lilly, Roche Diabetes Care, Ascensia Diabetes Care |
Other key industry trends
- In terms of revenue, UK accounted for 4.3% of the global pediatric diabetes management market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Europe, Germany pediatric diabetes management market is projected to lead the regional market in terms of revenue in 2033.
- France is the fastest growing regional market in Europe and is projected to reach USD 570.6 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Pediatric Diabetes Management Market Scope
Pediatric Diabetes Management Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Roche Diabetes Care | View profile | 5001-10000 | Burgdorf, Bern, Switzerland, Europe | https://www.rochediabetes.com/ |
| Eli Lilly | View profile | - | - | - |
| Abbott | View profile | - | - | - |
| Novo Nordisk A/S | View profile | - | - | - |
| Ascensia Diabetes Care | View profile | 1001-5000 | Basel, Basel-Stadt, Switzerland, Europe | http://www.ascensia.com/ |
| DexCom Inc | View profile | 9600 | 6340 Sequence Drive, San Diego, CA, United States, 92121 | https://www.dexcom.com |
| Tandem Diabetes Care Inc | View profile | 2400 | 12400 High Bluff Drive, San Diego, CA, United States, 92130 | https://www.tandemdiabetes.com |
| Insulet Corp | View profile | 3000 | 100 Nagog Park, Acton, MA, United States, 01720 | https://www.insulet.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Medtronic PLC | View profile | 95000 | Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 | https://www.medtronic.com |
UK pediatric diabetes management market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pediatric diabetes management market will help companies and investors design strategic landscapes.
Cgm was the largest segment with a revenue share of 38.15% in 2024. Horizon Databook has segmented the UK pediatric diabetes management market based on bgm, cgm, insulin pumps, insulin pens, insulin syringes covering the revenue growth of each sub-segment from 2021 to 2033.
The rising prevalence of diabetes is a primary driver of the pediatric diabetes management market in the UK with increasing rates of obesity contributing significantly to the surge in cases.
Furthermore, government initiatives and healthcare policies focused on early diagnosis and improved diabetes management are also playing a crucial role, creating a favorable environment for market growth.
The UK's National Health Service (NHS) commitment to providing comprehensive diabetes care, including access to innovative treatments and technologies, further supports market expansion in the country.
Reasons to subscribe to UK pediatric diabetes management market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UK pediatric diabetes management market databook
-
Our clientele includes a mix of pediatric diabetes management market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UK pediatric diabetes management market , including forecasts for subscribers. This country databook contains high-level insights into UK pediatric diabetes management market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
UK pediatric diabetes management market size, by product, 2021-2033 (US$M)
UK Pediatric Diabetes Management Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
